SCHEMBL4776816

SCHEMBL4776816

CCn1c(-c2ccc(Cl)cc2)nc2c(=O)[nH]c(-c3cccc(C(F)(F)F)c3)nc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 1/20 0.45
MAPK14 Q16539 1/20 0.42
HTT P42858 3/20 0.42
CYP1A2 P05177 3/20 0.42
CYP3A4 P08684 3/20 0.42
CYP2C9 P11712 3/20 0.42
KDM4E B2RXH2 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MEN1 O00255 1/20 0.42
NPC1 O15118 1/20 0.42
ALDH1A1 P00352 1/20 0.42
THRB P10828 1/20 0.42
PKM P14618 1/20 0.42
HPGD P15428 1/20 0.42
TSHR P16473 1/20 0.42
STAT6 P42226 1/20 0.42
RAB9A P51151 1/20 0.42
KMT2A Q03164 1/20 0.42
HIF1A Q16665 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4774140 0.85 HTT (0.46) HTTMEN1KMT2AADORA2BADORA1
SCHEMBL4774467 0.80 ALDH1A1 (0.40) MAPK14KDM4EMEN1ALDH1A1PKM
SCHEMBL5769313 0.77 ALDH1A1 (0.47) HTTKDM4ESMN1; SMN2MEN1ALDH1A1
SCHEMBL5768343 0.76 ALDH1A1 (0.38) KDM4EALDH1A1PKMHPGDTSHR
SCHEMBL5768878 0.75 EIF4E (0.36) CYP3A4CYP2C9KDM4EMEN1ALDH1A1
SCHEMBL5768875 0.75 ALDH1A1 (0.35) KDM4EALDH1A1PKMHPGDTSHR
SCHEMBL5769810 0.74 ALDH1A1 (0.40) HTTKDM4EMEN1ALDH1A1PKM
SCHEMBL4776139 0.73 ALDH1A1 (0.41) HTTKDM4EMEN1ALDH1A1PKM
SCHEMBL4767126 0.73 HPGD (0.39) HTTKDM4EMEN1ALDH1A1PKM
SCHEMBL5770531 0.73 KDM4E (0.39) KDM4EMEN1NPC1ALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1881988-A1 2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LTD. (GB) 2008-01-30 EP disclosed
WO-2006122200-A1 2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LIMITED (GB) 2006-11-16 WO disclosed